Skip to main content
SpringerLink
Log in

Risk factors, prophylaxis and therapy of X-ray contrast media reactions

  • Chapter
Advances in X-Ray Contrast

  • 139 Accesses

Abstract

Although the radiocontrast media (RCM) used routinely for the past 30 years are relatively safe drugs, adverse reactions to these conventional, ionic contrast agents can be expected with an overall frequency of 5–12% [1–5]. In one out of every 1000 examinations, a reaction of life-threatening severity may occur [6,7].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ansell G. Adverse reactions to contrast agents. Scope of problem. Invest Radiol. 1990; 25: 381.

    Article  PubMed  CAS  Google Scholar 

  2. Hartman G, Hattery R, Witten D, Williamson B. Mortality during excretory urography: Mayo Clinic experience. AJR. 1982; 139: 919–922.

    PubMed  CAS  Google Scholar 

  3. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and non-ionic contrast media: a report from the Japanese Committee on the Safety of Contrast Media. Radiology. 1990; 175: 621–628.

    PubMed  CAS  Google Scholar 

  4. Swanson D, Shetty P, Kastan D, Rollins N. Angiographic contrast media. In: Swanson D, Chilton H, Thrall J, eds. Pharmaceuticals in Medical Imaging. New York: Macmillan, 1990: 13–39.

    Google Scholar 

  5. Witten D, Hirisch F, Hartman G. Acute reactions to contrast media: incidence, clinical characteristics and relationship to history of hypersensitivity states. AJR. 1973; 119: 832–840.

    CAS  Google Scholar 

  6. Davies P, Roberts M, Roylance J. Acute reactions to urographic contrast media. Br Med J. 1975; 2: 434–437.

    Article  PubMed  CAS  Google Scholar 

  7. Shehadi W, Toniolo G. Adverse reactions to contrast media. Radiology. 1980; 137: 299–302.

    PubMed  CAS  Google Scholar 

  8. Baltaoglu G, Balkanci R, Tirnaksiz B. Fatal reaction after intra-arterial injection of non-ionic contrast medium [Letter]. AJR. 1994; 162:231.

    PubMed  CAS  Google Scholar 

  9. Curry N, Schabel S, Reiheld C, et al. Fatal reactions to intravenous non-ionic contrast material. Radiology. 1991; 178: 361–362.

    PubMed  CAS  Google Scholar 

  10. Westesson P, Manjione J. Reaction to non-ionic contrast medium during arthrography of the temporalmandibular joint [Letter]. AJR. 1990; 154: 1344.

    PubMed  CAS  Google Scholar 

  11. Wolf G, Arenson R, Cross A. A prospective trial of ionic vs non-ionic contrast agents in routine clinical practice: comparison of adverse effects. AJR. 1989; 152: 939–944.

    PubMed  CAS  Google Scholar 

  12. Almen T. The etiology of contrast medium reactions. Invest Radiol. 1994; 29(Suppl 1): S37–S45.

    Article  PubMed  CAS  Google Scholar 

  13. Greenberger P. Contrast media reactions. J Allergy Clin Immunol. 1984; 74: 600.

    Article  PubMed  CAS  Google Scholar 

  14. Brasch R, Caldwell J. The allergic theory of radiographic contrast toxicity: demonstration of antibody activity in sera of patients suffering major radiocontrast agent reactions. Invest Radiol. 1976; 11:347–356.

    Article  PubMed  CAS  Google Scholar 

  15. Carr D, Walker A. Contrast media reactions: experimental evidence against the allergy theory. Br J Radiol. 1984; 57: 469–473.

    Article  PubMed  CAS  Google Scholar 

  16. Lasser E, Slivka J, Lang J, et al. Complement and coagulation-causative considerations in contrast catastrophies. AJR. 1979; 132: 171–176.

    PubMed  CAS  Google Scholar 

  17. Assem E, Bray K, Dawson P. The release of histamine from human basophils by radiological contrast agents. Br J Radiol. 1983; 56: 647–652.

    Article  PubMed  CAS  Google Scholar 

  18. Robertson P, Frewin D, Robertson A, Mahar L, Jonsson J. Plasma histamine levels following administration of radiographic contrast media. Br J Radiol. 1985; 58: 1047.

    Article  PubMed  CAS  Google Scholar 

  19. Littner M, Ulreich S, Putman C, Rosenfield A, Meadows G. Bronchospasm during excretory urography. AJR. 1981; 137: 477–481.

    PubMed  CAS  Google Scholar 

  20. Cogan F, Norman M, Dunsky E, Hirshfeld J, Zweiman B. Histamine release and complement changes following injection of contrast media in humans. J Allergy Clin Immunol. 1979; 64: 299–303.

    Article  Google Scholar 

  21. Lasser E. A coherent biochemical basis for increased reactivity to contrast material in allergic patients: a novel concept. AJR. 1987; 149: 1281–1285.

    PubMed  CAS  Google Scholar 

  22. Lasser E, Lang J, Lyon S, Hamblin A, Howard M. Prekallikrein-kallikrein conversion rate as a predictor of contrast media catastrophies. Radiology. 1981; 140: 11–15.

    PubMed  CAS  Google Scholar 

  23. Lieberman P, Siegle R. Complement activation following intravenous contrast material administration. J Allergy Clin Immunol. 1979; 64: 13–17.

    Article  PubMed  CAS  Google Scholar 

  24. Zipser R, Laffi G. Prostaglandins, thromboxanes, and leukotrienes in clinical medicine. West J Med. 1985; 143: 485–497.

    PubMed  CAS  Google Scholar 

  25. Dawson P, Edgerton D. Contrast media and enzyme inhibition. I. Cholinesterase. Br J Radiol. 1983; 56: 653–656.

    Article  PubMed  CAS  Google Scholar 

  26. Lalli A. Contrast media reactions: Data analysis and hypothesis. Radiology. 1980; 134: 1–12.

    PubMed  CAS  Google Scholar 

  27. Hayakawa K, Morris T, Katzberg R. Opening of the blood-brain barrier by intravenous contrast media in euvolemic and dehydrated rabbits. Acta Radiol. 1989; 30: 439–444.

    Article  PubMed  CAS  Google Scholar 

  28. Wilson A, Evill C, Sage M. Effects of non-ionic contrast media on the blood-brain barrier: osmolality versus chemotoxicity. Invest Radiol. 1991; 26: 1091–1094.

    Article  PubMed  CAS  Google Scholar 

  29. Lawrence V, Matthai W, Hartmaier S. Comparative safety of high-osmolality and low-osmolality radiographic contrast agents. Report of a multidisciplinary working group. Invest Radiol. 1992; 27: 2–28.

    Article  PubMed  CAS  Google Scholar 

  30. Caro J, Trindale E, McGregor M. The risks of death and of severe nonfatal reactions with high-vs low-osmolality contrast media: a meta-analysis. AJR. 1991; 156: 825–832.

    PubMed  CAS  Google Scholar 

  31. Gerstman B. Epidemiologic critique of the report on adverse reactions to ionic and non-ionic media by the Japanese Committee on the Safety of Contrast Media. Radiology. 1991; 178: 787–790.

    PubMed  CAS  Google Scholar 

  32. Kinnison M, Powe N, Steinberg E. Results of randomized controlled trials of low-vs high-osmolality contrast media. Radiology. 1989; 170: 381–389.

    PubMed  CAS  Google Scholar 

  33. Palmer F. The R.A.C.R. survey of intravenous contrast media reactions: final report. Australas Radiol. 1988; 32: 426–428.

    Article  PubMed  CAS  Google Scholar 

  34. Siegle R. Rates of idiosyncratic reactions. Ionic versus non-ionic contrast media. Invest Radiol. 1993; 28: S95–S98.

    Article  PubMed  Google Scholar 

  35. Shehadi W. Death following intravascular administration of contrast media. Acta Radiol Diagn. 1985; 26: 457–461.

    CAS  Google Scholar 

  36. Bush W, McClennan B, Swanson D. Contrast media reactions: prediction, prevention, and treatment. Postgrad Radiol. 1993; 13: 137–147.

    Google Scholar 

  37. Shellock F, Hahn H, Mink J, Itskovich E. Adverse reaction to intravenous gadoteridol. Radiology. 1993; 189: 151–152.

    PubMed  CAS  Google Scholar 

  38. Yoshikawa H. Late adverse reactions to non-ionic contrast media. Radiology. 1992; 183: 737–740.

    PubMed  CAS  Google Scholar 

  39. McCullough M, Davies P, Richardson R. A large trial of intravenous Conray 325 and Niopam 300 to assess immediate and delayed reactions. Br J Radiol. 1989; 62: 260–265.

    Article  PubMed  CAS  Google Scholar 

  40. Lang D, Allpern M, Visintainer P, Smith S. Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma. Ann Intern Med. 1991; 115: 270–276.

    PubMed  CAS  Google Scholar 

  41. Thrall J. Adverse reactions to contrast media: etiology, incidence, treatment, prevention. In: Swanson DP, Chilton HM, Thrall JH, eds. Pharmaceuticals in Medical Imaging. New York: Macmillan, 1990: 253–277.

    Google Scholar 

  42. Greenberger P, Meyers S, Kramer B. Effects of beta-adrenergic and calcium antagonists on the development of anaphylactoid reactions from radiographic contrast media during cardiac angiography. J Allergy Clin Immunol. 1987; 80: 698–702.

    Article  PubMed  CAS  Google Scholar 

  43. Fishman J, Aberle D, Moldawer N, Belldegrun A, Figlin R. Atypical contrast reactions associated with systemic interleukin-2 therapy. AJR. 1991; 156: 833–834.

    PubMed  CAS  Google Scholar 

  44. Oldham R, Brogley J, Braud E. Contrast media ‘recalls’ interleukin-2 toxicity. [Letter to the Editor]. J Clin Oncol. 1990; 8: 942.

    PubMed  CAS  Google Scholar 

  45. Shulman K, Thompson J, Benyunes M, Winter T, Fefer A. Adverse reactions to intravenous contrast media in patients treated with interleukin-2. J Immunother. 1993; 13: 208–212.

    Article  CAS  Google Scholar 

  46. Zukiwski A, David C, Coan J, Wallace S, Gutterman J, Mavligit G. Increased incidence of hypersensitivity to iodine-containing radiographic contrast media after interleukin-2 administration. Cancer. 1990; 65: 1521–1524.

    Article  PubMed  CAS  Google Scholar 

  47. Sirtori C, Pask C. Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res. 1994; 30: 187–228.

    Article  PubMed  CAS  Google Scholar 

  48. Fischer H, Doust V. An evaluation of pretesting in the problem of serious and fatal reactions to excretory urography. Radiology. 1972; 103: 497–501.

    PubMed  CAS  Google Scholar 

  49. Witten D. Reactions to urographic contrast media. JAMA. 1975; 231: 974–977.

    Article  PubMed  CAS  Google Scholar 

  50. Siegle R, Halvosen R, Dillon J, Gavant M, Halperon E. The use of iohexol in patients with previous reactions to ionic contrast material. Invest Radiol. 1991; 26: 411–416.

    Article  PubMed  CAS  Google Scholar 

  51. Solomon R, Werner C, Mann D, D’Elia J, Suva P. Effects of saline, mannitol, and furosemide in acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994; 331: 1416–1420.

    Article  PubMed  CAS  Google Scholar 

  52. Lautin E, Freeman N, Schoenfield A, et al. Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high osmolality contrast media. AJR. 1991; 157:59–65.

    PubMed  CAS  Google Scholar 

  53. Lautin E, Freeman N, Schoenfield A, et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR. 1991; 157: 49–58.

    PubMed  CAS  Google Scholar 

  54. Shehadi W. Contrast media adverse reactions: occurrence, recurrence, and distribution patterns. Radiology. 1982; 143: 11–17.

    PubMed  CAS  Google Scholar 

  55. Yamaguchi K, Katayama H, Takashima T, Kozuka T, Seez P, Matsuura K. Prediction of severe adverse reactions to ionic and non-ionic contrast media in Japan: evaluation of pretesting. Radiology. 1991; 178: 363–367.

    PubMed  CAS  Google Scholar 

  56. Dunnick N, Cohan R. Cost, corticosteroids, and contrast media [commentary]. AJR. 1994; 162: 527–529.

    PubMed  CAS  Google Scholar 

  57. Greenberger P, Patterson R. The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol. 1991; 87: 867–872.

    Article  PubMed  CAS  Google Scholar 

  58. Kelly J, Patterson R, Lieberman P, Mathison D, Sevenson D. Radiographic contrast media studies in high-risk patients. J Allergy Clin Immunol. 1978; 62: 181–184.

    Article  PubMed  CAS  Google Scholar 

  59. Lasser E, Berry C, Mishkin M, Williamson B, Zheutlin N, Silverman J. Pretreatment with corticosteroids to prevent adverse reactions to non-ionic contrast media. AJR. 1994; 162: 523–526.

    PubMed  CAS  Google Scholar 

  60. Lasser E, Berry C, Talner L, et al. Protective effects of corticosteroids in contrast material anaphylaxis. Invest Radiol. 1988; 23(Suppl 1): S193–S194.

    Article  PubMed  Google Scholar 

  61. Lasser E, Lang J, Sovak M, Kolb W, Lyon S, Hamlin A. Steroids: theoretical and experimental basis for utilization in prevention of contrast media reactions. Radiology. 1977; 125: 1–9.

    PubMed  CAS  Google Scholar 

  62. Greenberger P, Patterson R, Tapio C. Prophylaxis against repeated radiocontrast media reactions in 857 cases. Arch Intern Med. 1985; 145: 2197–2200.

    Article  PubMed  CAS  Google Scholar 

  63. Lasser E, Berry C, Talner L, et al. Pretreatment with corticosteroids to alleviate reactions to intravascular contrast media. N Engl J Med. 1987; 317: 845–849.

    Article  PubMed  CAS  Google Scholar 

  64. Dawson P, Sidhu P. Is there a role for corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrast agents? [Review]. Clin Radiol 1993; 48: 225–226.

    Article  PubMed  CAS  Google Scholar 

  65. Luna-Fineman S, Healy M, Parker B. Corticosteroid pretreatment for potential contrast reactions in children with lymphoreticular cancer: a word of caution. AJR. 1990; 155: 357–358.

    PubMed  CAS  Google Scholar 

  66. Bush W, Swanson D. Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. AJR 1991; 157: 1153–1161.

    PubMed  CAS  Google Scholar 

  67. Cohan R, Dunnick N. Treatment of reactions to radiologic contrast material. AJR. 1988; 151: 263–267.

    PubMed  CAS  Google Scholar 

  68. McClennan B. Adverse reactions to iodinated contrast media. Recognition and response. Invest Radiol. 1994; 29(Suppl 1): S46–S50.

    Article  PubMed  Google Scholar 

  69. Siegle R, Lieberman P. A review of untoward reactions to iodinated contrast material. J Urol. 1978; 119: 581–587.

    PubMed  CAS  Google Scholar 

  70. van Sonnenberg E, Neff C, Pfister R. Life-threatening hypotensive reactions to contrast media administration: comparison of pharmacologic and fluid therapy. Radiology. 1987; 162: 15–19.

    Google Scholar 

  71. Smith M, Kendall B, Tomlinson S. Adverse general reactions to high doses of methylglucamine-based contrast media. Br J Radiol. 1974; 47: 566–569.

    Article  PubMed  CAS  Google Scholar 

  72. Brown J. Atropine, scopolamine, and antimuscarinic drugs. In: Gilman A, Rail T, Nies A, Taylor P, eds. The Pharmocological Basis of Therapeutics. New York: McGraw-Hill Publishers, 1990: 150–165.

    Google Scholar 

  73. Chamberlain D, Turner P, Sneddon J. Effects of atropine on heart-rate in healthy man. Lancet. 1967; 2: 12–15.

    Article  PubMed  CAS  Google Scholar 

  74. Stanley R, Pfister R. Bradycardia and hypotension following use of intravenous contrast media. Radiology. 1976; 121: 5–7.

    PubMed  CAS  Google Scholar 

  75. Barach E, Nowak R, Tennyson G, Tomlanovich M. Epinephrine for treatment of anaphylactic shock. JAMA. 1984; 251: 2118–2122.

    Article  PubMed  CAS  Google Scholar 

  76. Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care III: adult advanced cardiac life support. JAMA. 1992; 268: 2199–2241.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, University of Washington School of Medicine, Box 357115, 1959 NE Pacific Street, Seattle, WA, 98195, USA

    William H. Bush Jr MD, FACR

Authors
  1. William H. Bush Jr MD, FACR
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Imaging, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK

    P. Dawson

  2. Schering AG, Clinical Development, Monomeric X-Ray Contrast Media, Berlin, Germany

    W. Clauss

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Bush, W.H. (1998). Risk factors, prophylaxis and therapy of X-ray contrast media reactions. In: Dawson, P., Clauss, W. (eds) Advances in X-Ray Contrast. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3959-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-3959-5_13

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-7923-8741-1

  • Online ISBN: 978-94-011-3959-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation